@uranium69 The source of your info is outdated, they didn't...

@uranium69

The source of your info is outdated, they didn't really reflect the real data, institutional nominees accounts hold around 1/3 of the company shares. Former chair subscribed 720k shares at 70c to the IPO, he also had a loan facility with Morgan Stanley for 4.8m shares, so my guess is he had to sell some shares to repay his loan.




Our MD actually personally invested in around $500k in LLL, bought 400k FFX to receive in specie distribution of 285,714 LLL shares, then subscribed IPO at 70c for 180,291, and bought more on market for 260,585, Simon also holds 5 million performance option with exercise price at 64.4c;

Our new chairman, bought on market 160,000 shares before the appointment;

Amber, also invested ~$600k in LLL, bought FFX to receive in specie distribution of 288,970, then subscribed $200k at 70c, and bought further 298,022 shares at average 67.1c.

Rod, subscribed 41,536 at IPO.

Brendan, 8.5m from in-specie distribution, subscribed $813k at 70c, bought further 366,908 on market.





Always DYOR. ALL IMO.